Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/23/1999 | EP0924300A2 DNA sequences for an amino acid transporter, plasmids, bacteria, yeasts and plants containing a transporter and their use |
06/23/1999 | EP0924299A1 Transit peptide DNA sequence |
06/23/1999 | EP0924297A1 Sialoadhesin family member-2 (saf-2) |
06/23/1999 | EP0924295A2 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
06/23/1999 | EP0923648A1 Gene conferring disease resistance in plants and uses thereof |
06/23/1999 | EP0923644A1 G-coupled receptor showing selective affinity for atp |
06/23/1999 | EP0923643A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
06/23/1999 | EP0923642A1 Active survival domains of igf-ir and methods of use |
06/23/1999 | EP0923640A1 Embryonic and adult cns stem cells |
06/23/1999 | EP0923607A1 Method for producing polyclonal and monoclonal antibodies |
06/23/1999 | EP0923606A1 ANTIGENIC FUSIONPROTEIN CARRYING GAL$g(a)1,3GAL EPITOPES |
06/23/1999 | EP0923388A1 Use of microorganisms for processing bioprosthetic tissue |
06/23/1999 | EP0923308A1 Purification of biologically active peptides from milk |
06/23/1999 | EP0923284A1 Cellular immunogens useful as cancer vaccines |
06/23/1999 | EP0733101A4 Glucose responsive insulin secreting beta-cell lines and method for producing same |
06/23/1999 | EP0722494A4 Transgenic plants that exhibit enhanced nitrogen assimilation |
06/23/1999 | EP0690876B1 Protein kinases |
06/23/1999 | EP0628639B1 Reconstituted human antibody against human interleukin 6 receptor |
06/23/1999 | EP0605522B1 Methods for the production of humanized antibodies |
06/23/1999 | CN1220701A Lipid kinase |
06/23/1999 | CN1220700A Antifungal polypeptide and methods for controlling plant pathogenic fungi |
06/23/1999 | CN1220699A Antibodies against interferon alpha/beta receptor |
06/23/1999 | CN1220696A Stabilization of blood platelets against low temp. activation |
06/23/1999 | CN1220270A Improved process for stabilizing proteins |
06/23/1999 | CA2256052A1 Genes of purine biosynthesis from ashbya gossypii and the use thereof in microbial riboflavin synthesis |
06/22/1999 | US5914451 Efficiency soybean transformation protocol |
06/22/1999 | US5914391 Stabilized compositions containing hemoglobin |
06/22/1999 | US5914317 A dna which hybridizes under high stringency conditions to a preferential dna sequence encodes b1k proteins which contains atleast thirty amino acid residues in length; useful for treating dermis disorder such as epidermal bulosis |
06/22/1999 | US5914315 Isolated amino acid sequences encoding a kunitz-type inhibitor; anticoagulants for treating deep vein thrombosis |
06/22/1999 | US5914270 Method for promoting the differentiation of plant cells in culture |
06/22/1999 | US5914268 Embryonic cell populations and methods to isolate such populations |
06/22/1999 | US5914264 Apparatus for growing vertebrate skin in vitro |
06/22/1999 | US5914262 Vessel containing suspension of cells encapsulated in polymer beads, detector to noninvasively distinguish characteristics (e.g. viability), controller to direct and separate classes of beads; for rapid and automatic analysis |
06/22/1999 | US5914260 Fish pancreatic disease virus |
06/22/1999 | US5914253 Dna coding for protein from mouse liver; anticarcinogenic/antitumor agents; platelet activator; antiseptic; viricides |
06/22/1999 | US5914251 Nucleic acid molecules encoding placental-derived growth factors |
06/22/1999 | US5914243 Process for the immunochemical determination of an analyte |
06/22/1999 | US5914234 Methods of detecting growth differentiation factor-11 |
06/22/1999 | US5914231 Carrier of cationic, water soluble or water dispersable polymer; for gene therapy |
06/22/1999 | US5914182 Polymeric surfactants attached onto the surfaces of a support member and covalently cross-linked thereon to form a first layer. hydrophilic polymers are then attached to the first layer on the support member to form a second layer thereon. |
06/22/1999 | US5914121 Formation of human bone in vivo using ceramic powder and human marrow stromal fibroblasts |
06/22/1999 | US5914109 Heterohybridomas producing human monoclonal antibodies to HIV-1 |
06/22/1999 | US5914108 Implanting a cellular composition containing greater than 90% human hematopoietic stem cells thy-1+, capable of self-regeneration in a coculture medium and capable of differentiation to members of all hematopoietic lineages |
06/22/1999 | US5914070 Gas concentration adjusting agent, gas concentration adjusting method, and gas concentration adjusting system |
06/22/1999 | CA1340607C Homogenous mammalian hematopoietic stem cell composition |
06/22/1999 | CA1340605C Isolation and characterization of telomere sequences of a.thaliana |
06/17/1999 | WO1999030151A1 Method and cells to screen combinatorial libraries |
06/17/1999 | WO1999029906A2 Gene family with transformation modulating activity |
06/17/1999 | WO1999029896A1 Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof |
06/17/1999 | WO1999029882A2 Methods for altering the nutritional value of a plant protein, vegetative storage protein, vsp, by altering the amino acid content of proteins |
06/17/1999 | WO1999029880A2 Method for producing transgenic plants with modified 5-aminolevulinic acid biosynthesis, method for identifying 5-aminolevulinic acid synthesis effectors |
06/17/1999 | WO1999029879A1 VEGETABLE GntI SEQUENCES AND THE USE THEREOF TO OBTAIN PLANTS WITH A REDUCED OR LACK OF N-ACETYLGLUCOSAMINYLTRANSFERASE I (GnTI) ACTIVITY |
06/17/1999 | WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
06/17/1999 | WO1999029873A1 Cyclic gmp phosphodiesterase |
06/17/1999 | WO1999029871A2 Circovirus sequences related to piglet weight loss disease (pwd) |
06/17/1999 | WO1999029870A1 Porphorymonas gingivalis polypeptides and nucleotides |
06/17/1999 | WO1999029863A1 Human interferon-epsilon: a type i interferon |
06/17/1999 | WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto |
06/17/1999 | WO1999029858A1 Soluble inhibitors of vascular endothelial growth factor and use thereof |
06/17/1999 | WO1999029856A1 Restin and methods of use thereof |
06/17/1999 | WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof |
06/17/1999 | WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto |
06/17/1999 | WO1999029849A1 G-protein coupled receptors associated with immune response |
06/17/1999 | WO1999029843A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
06/17/1999 | WO1999029841A1 Purification and microsequencing of hyaluronidase isozymes |
06/17/1999 | WO1999029834A1 Methods for preparation of vaccines against cancer |
06/17/1999 | WO1999029730A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna |
06/17/1999 | WO1999029725A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5 |
06/17/1999 | WO1999029723A1 Recombinant nodavirus compositions and methods |
06/17/1999 | WO1999029722A1 DNA MOLECULES ENCODING VERTEBRATE NUCLEAR RECEPTOR PROTEIN, nNR4 |
06/17/1999 | WO1999029718A2 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof |
06/17/1999 | WO1999029717A2 Postweaning multisystemic wasting syndrome virus from pigs |
06/17/1999 | WO1999029715A1 Tumor antigen peptide derivatives |
06/17/1999 | WO1999029279A2 Long-term survival and regeneration of central nervous system neurons |
06/17/1999 | WO1999029160A1 STRAIN MANIPULATION AND IMPROVEMENT IN THE EDIBLE SEAWEED $i(PORPHYRA) |
06/17/1999 | WO1999017796A3 Modulation of lerk-2-mediated cell adhesion |
06/17/1999 | WO1999016887A3 Compositions and methods for identifying pkb kinase inhibitors |
06/17/1999 | WO1999016460A3 Apolipoprotein e/growth factor complexes and methods of use |
06/17/1999 | WO1999013064A3 Viral infection of cells using viral vectors |
06/17/1999 | WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene |
06/17/1999 | WO1999007739A8 Dna encoding the human synapsin iii gene and uses thereof |
06/17/1999 | DE19754929A1 Verfahren zur Herstellung transgener Pflanzen mit veränderter 5-Aminolävulinsäure-Biosynthese und Verfahren zur Identifizierung von Effektoren der 5-Aminolävulinsäure Synthese A method for producing transgenic plants with altered 5-aminolevulinic acid biosynthesis and method for identifying effectors of 5-aminolevulinic acid synthesis |
06/17/1999 | DE19754774A1 Transgenes nicht-menschliches Säugetier mit einer onkogenen Mutante des Raf-1-Gens A transgenic non-human mammal with an oncogenic mutant of the Raf-1 gene |
06/17/1999 | CA2315273A1 Dna molecules encoding vertebrate nuclear receptor protein, nnr4 |
06/17/1999 | CA2314434A1 Dna molecules encoding human nuclear receptor protein, nnr5 |
06/17/1999 | CA2314005A1 Methods for preparation of vaccines against cancer |
06/17/1999 | CA2313823A1 Porphorymonas gingivalis polypeptides and nucleotides |
06/17/1999 | CA2313806A1 Postweaning multisystemic wasting syndrome virus from pigs |
06/17/1999 | CA2313706A1 Method for producing transgenic plants with modified 5-aminolevulinic acid biosynthesis, method for identifying 5-aminolevulinic acid synthesis effectors |
06/17/1999 | CA2313705A1 Restin and methods of use thereof |
06/17/1999 | CA2313451A1 Cyclic gmp phosphodiesterase |
06/17/1999 | CA2313450A1 G-protein coupled receptors associated with immune response |
06/17/1999 | CA2313381A1 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof |
06/17/1999 | CA2313350A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna |
06/17/1999 | CA2313348A1 Soluble inhibitors of vascular endothelial growth factor and use thereof |
06/17/1999 | CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
06/17/1999 | CA2312734A1 Vegetable gnti sequences and the use thereof to obtain plants with a reduced or lack of n-acetylglucosaminyltransferase i (gnti) activity |
06/17/1999 | CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto |
06/17/1999 | CA2312484A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
06/17/1999 | CA2312289A1 Tumor antigen peptide derivatives |